SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Small Cap Foreign Biotech
An SI Board Since January 2000
Posts SubjectMarks Bans
363 30 0
Emcee:  RWReeves Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
288<i>I was a little bit surprised</i> ...the breadth of my general knonigel bates-7/4/2003
287I was a little bit surprised to see that Nigel keeps a check on Active Biotech. Icebrg-7/4/2003
286NeuTec Pharma announces encouraging phase IIb dataon its MRSA drug, Aurograb 13nigel bates-6/13/2003
285From Protherics results statement: <pre> CHIEF nigel bates-6/4/2003
284Another one facing the cash crunch (the trial failure was actually announced on nigel bates-1/20/2003
283SAN DIEGO, Dec. 20 /PRNewswire-FirstCall/ -- Proteome Sciences plc (Proteome Scinigel bates-12/20/2002
282$10 million for Procyon - La Financiere du Quebec Makes Its First Biolevier Loanthebeach-12/13/2002
281Little drug firm may be big winner Amarin, a small-cap orphan, pursues nerve diskeokalani'nui-12/4/2002
280Nigel, The BSE and CJD tests are interesting. Do you have any idea of the royaA.J. Mullen-12/3/2002
279PROTHERICS PLC NTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2002 Prothenigel bates-12/3/2002
278I was disappointed, too. Still, I'll be out again soonish, although the M-nigel bates-11/25/2002
27725 November 2002 PROTHERICS REDEEMS CONVERTIBLE DEBENTURES OPTION Protherics PLCnigel bates-11/25/2002
276Hi Nigel , Sorry I missed you on your recent visit. Been busy, as the Home OffiRWReeves-11/20/2002
275Xenova gets fast track status for Tarquidar. And a new thread - Subject 53357nigel bates-10/3/2002
274just noodling around this a.m. and found XNVA and am intrigued. I think this miMoneyPenny-9/25/2002
273Xenova rights issue. Not exactly great timing, in any respect. Slough, UK, 11 Snigel bates-9/11/2002
272<i>one of my long term positions although it has given me much pain...<nigel bates-7/4/2002
271Hello Nigel, thanks for the post. QLT is one of my long term positions although RWReeves-7/4/2002
270VANCOUVER, June 28 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI) announced tonigel bates-6/28/2002
269Hey, if it shows demonstrates any efficacy, I fully expect California to introdunigel bates-6/14/2002
268<i>This double-blind, randomised, placebo-controlled study was designed toscaram(o)uche-6/14/2002
267SLOUGH, England, June 14 /PRNewswire-FirstCall/ -- Xenova Group plc (Nasdaq NM: nigel bates-6/14/2002
26622 May 2002 Vernalis commences clinical trials in obesity Vernalis Group plc (nigel bates-5/22/2002
26514 May 2002 Roche and Vernalis announce new collaboration in depression and anxinigel bates-5/14/2002
264BTW, Other venomous snakes aren't as smart as rattlers. The overall incidetuck-5/5/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News